Financhill
Buy
56

ACAD Quote, Financials, Valuation and Earnings

Last price:
$27.87
Seasonality move :
14.5%
Day range:
$27.65 - $27.96
52-week range:
$13.40 - $28.35
Dividend yield:
0%
P/E ratio:
17.93x
P/S ratio:
4.48x
P/B ratio:
5.14x
Volume:
1M
Avg. volume:
1.5M
1-year change:
63.27%
Market cap:
$4.7B
Revenue:
$957.8M
EPS (TTM):
$1.55

Earnings Data

Next earnings date for ACAD
Feb 25
2026
Most recent earnings per share
$0.42
Beat by $0.28
(Nov 5/2025)
Consensus Estimate
$0.15
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ACAD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $293.2M -- -- $0.14 --
11/05/2025 Q3 $277.2M $278.6M $0.42 $0.15 $0.28
08/06/2025 Q2 $262.2M $264.6M $0.16 $0.14 $0.02
05/08/2025 Q1 $239M $244.3M $0.11 $0.11 $0.01
02/26/2025 Q4 $272.1M $259.6M $0.86 $0.22 $0.64
11/06/2024 Q3 $248.8M $250.4M $0.20 $0.14 $0.06
08/06/2024 Q2 $235.7M $242M $0.20 $0.18 $0.02
05/08/2024 Q1 $208.6M $205.8M $0.10 $0.06 $0.04
02/27/2024 Q4 $223.8M $231M $0.28 $0.31 -$0.03
11/02/2023 Q3 -- -- -$0.40 -$0.42 $0.02
08/02/2023 Q2 -- -- $0.01 -$0.12 $0.13
05/08/2023 Q1 -- -- -$0.27 -$0.21 -$0.06
02/27/2023 Q4 -- -- -$0.26 -$0.25 -$0.01
11/02/2022 Q3 -- -- -$0.17 -$0.20 $0.03
08/08/2022 Q2 -- -- -$0.21 -$0.25 $0.04
05/04/2022 Q1 -- -- -$0.70 -$0.60 -$0.10
02/28/2022 Q4 -- -- -$0.27 -$0.24 -$0.03
11/08/2021 Q3 -- -- -$0.09 -$0.26 $0.17
08/04/2021 Q2 -- -- -$0.27 -$0.30 $0.03
05/05/2021 Q1 -- -- -$0.42 -- --
02/24/2021 Q4 -- -- -$0.42 -- --
11/04/2020 Q3 -- -- -$0.54 -- --
08/05/2020 Q2 -- -- -$0.27 -- --
05/07/2020 Q1 -- -- -$0.57 -- --
02/26/2020 Q4 -- -- -$0.34 -- --
10/30/2019 Q3 -- -- -$0.29 -- --
07/31/2019 Q2 -- -- -$0.38 -- --
05/01/2019 Q1 -- -- -$0.59 -- --
02/26/2019 Q4 -- -- -$0.50 -- --
11/06/2018 Q3 -- -- -$0.50 -- --
08/08/2018 Q2 -- -- -$0.51 -- --
05/04/2018 Q1 -- -- -$0.44 -- --
02/27/2018 Q4 -- -- -$0.55 -- --
11/07/2017 Q3 -- -- -$0.53 -- --
08/08/2017 Q2 -- -- -$0.55 -- --
05/09/2017 Q1 -- -- -$0.72 -- --
02/28/2017 Q4 -- -- -$0.65 -- --
11/07/2016 Q3 -- -- -$0.61 -- --
08/04/2016 Q2 -- -- -$0.63 -- --
05/05/2016 Q1 -- -- -$0.45 -- --
02/29/2016 Q4 -- -- -$0.45 -- --

ACADIA Pharmaceuticals, Inc. Earnings Questions

  • How Much did ACADIA Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    ACADIA Pharmaceuticals, Inc. reported $278.6M worth of top line sales in its most recent quarter.

  • Did ACADIA Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    ACADIA Pharmaceuticals, Inc. announced earnings per share of $0.42 which represents a beat of analyst forecast a $0.15 per share.

  • Is ACADIA Pharmaceuticals, Inc. Profitable?

    ACADIA Pharmaceuticals, Inc. reported $257M that represents $1.51 per share over the last quarter.

  • What is the Analyst Consensus for ACADIA Pharmaceuticals, Inc. EPS Next Year?

    ACADIA Pharmaceuticals, Inc.'s earnings are forecast to decrease from $1.36 per share to $0.74 per share next year representing a decrease of -40.15%.

  • When is ACADIA Pharmaceuticals, Inc.'s Earnings Date?

    ACADIA Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock